Angiocrine Bioscience
Geoff Davis has extensive experience in the biotechnology industry, having held various leadership positions. Geoff served as the President and CSO at Angiocrine Bioscience, Inc., CEO at Angelica Therapeutics, and CSO at both Abgenix and Abgenix (now Amgen). Additionally, they have also been a Director at companies such as Vasoprep Surgical, Moerae Matrix, Inc., SDIX, Harbour Antibodies AB, Cell Genesys, and Repligen Corporation.
Geoff Davis obtained a Bachelor of Arts degree in Biology from Swarthmore College in 1973. Prior to that, they attended the University of California, San Francisco from 1976 to 1981. Other educational institutions mentioned include Pomona College and The Ranney School.
This person is not in any offices
Angiocrine Bioscience
Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.